284 related articles for article (PubMed ID: 11602384)
1. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
2. Laboratory diagnosis of hereditary thrombophilia.
Michiels JJ; Hamulyák K
Semin Thromb Hemost; 1998; 24(4):309-20. PubMed ID: 9763348
[TBL] [Abstract][Full Text] [Related]
3. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study.
Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A
Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524
[TBL] [Abstract][Full Text] [Related]
4. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway.
Toulon P; Perez P
Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561
[TBL] [Abstract][Full Text] [Related]
5. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation.
Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P
Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046
[TBL] [Abstract][Full Text] [Related]
6. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation.
Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806
[TBL] [Abstract][Full Text] [Related]
7. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies.
Haas FJ; van Sterkenburg-Kamp BM; Scheepers HA
Semin Thromb Hemost; 1998; 24(4):355-62. PubMed ID: 9763352
[TBL] [Abstract][Full Text] [Related]
8. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities.
Toulon P; Perez P; Rapp J; Adda R
Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017
[TBL] [Abstract][Full Text] [Related]
9. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
Favaloro EJ; Mirochnik O; McDonald D
Br J Biomed Sci; 1999; 56(1):23-33. PubMed ID: 10492912
[TBL] [Abstract][Full Text] [Related]
10. Pro CR global: an effective screening test for thrombophilia.
Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R
Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
Gessoni G; Valverde S
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Pro-C global for identification of defects in protein C/S anticoagulant pathway.
Bin Hanif T; Anwar J; Idrees M
J Ayub Med Coll Abbottabad; 2011; 23(1):89-91. PubMed ID: 22830156
[TBL] [Abstract][Full Text] [Related]
13. Another protein S functional assay is sensitive to resistance to activated protein C.
Faioni EM; Boyer-Neumann C; Franchi F; Wolf M; Meyer D; Mannucci PM
Thromb Haemost; 1994 Oct; 72(4):648. PubMed ID: 7878649
[No Abstract] [Full Text] [Related]
14. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
[TBL] [Abstract][Full Text] [Related]
15. Resistance to activated protein C: a major cause of inherited thrombophilia.
Jensen R; Ens GE
Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism.
Toulon P; Adda R; Perez P
Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753
[TBL] [Abstract][Full Text] [Related]
17. Hereditary deficiencies of antithrombin III, protein S, and the protein C pathway in Jordanian thrombosis patients.
Eid SS
Clin Lab Sci; 2002; 15(4):196-9. PubMed ID: 12776777
[TBL] [Abstract][Full Text] [Related]
18. [Hereditary disorders of the protein C system in central artery and branch arteriolar occlusions].
Greiner K; Hafner G; Prellwitz W; Pfeiffer N
Klin Monbl Augenheilkd; 1999 Jul; 215(1):33-6. PubMed ID: 10448635
[TBL] [Abstract][Full Text] [Related]
19. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk.
Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670
[TBL] [Abstract][Full Text] [Related]
20. Resistance to activated protein C as a basis for venous thrombosis.
Svensson PJ; Dahlbäck B
N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
